S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 TG TherapeuticsEvotecSchrödingerAllakosTurning Point Therapeutics
SymbolNASDAQ:TGTXOTCMKTS:EVTCYNASDAQ:SDGRNASDAQ:ALLKNASDAQ:TPTX
Price Information
Current Price$43.77$78.10$102.48$121.18$117.91
52 Week RangeBuyHoldBuyBuyBuy
MarketRank™
Overall Score1.80.51.31.21.9
Analysis Score3.50.01.41.34.5
Community Score3.32.53.62.33.1
Dividend Score0.00.00.00.00.0
Ownership Score1.70.00.82.51.7
Earnings & Valuation Score0.60.00.60.00.0
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$64.00N/A$88.75$133.00$153.57
% Upside from Price Target46.22% upsideN/A-13.40% downside9.75% upside30.24% upside
Trade Information
Market Cap$5.76 billion$6.42 billion$7.12 billion$6.36 billion$5.68 billion
Beta2.281.13N/A1.021.23
Average Volume1,541,7761,130802,272317,362260,944
Sales & Book Value
Annual Revenue$150,000.00$500.07 million$85.54 millionN/AN/A
Price / Sales38,368.7812.8583.25N/AN/A
CashflowN/A$1.43 per shareN/AN/AN/A
Price / CashN/A54.59N/AN/AN/A
Book Value$0.39 per share$7.08 per share($15.25) per share$10.19 per share$11.28 per share
Price / Book112.2311.03-6.72N/AN/A
Profitability
Net Income$-172,870,000.00$42.64 million$-24,570,000.00$-85,370,000.00$-72,130,000.00
EPS($1.83)$0.56N/A($1.89)($2.99)
Trailing P/E RatioN/A433.910.00N/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-151,798.69%3.92%-19.92%N/AN/A
Return on Equity (ROE)-223.96%3.96%-7.25%-29.18%-23.81%
Return on Assets (ROA)-108.08%1.61%-5.33%-27.70%-23.08%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.09%0.90%N/AN/AN/A
Current Ratio3.35%2.19%15.81%22.43%35.45%
Quick Ratio3.35%2.13%15.81%22.43%35.45%
Ownership Information
Institutional Ownership Percentage65.73%N/A41.29%65.35%81.31%
Insider Ownership Percentage13.20%N/AN/A44.77%23.20%
Miscellaneous
Employees2173,444392114130
Shares Outstanding131.49 million82.26 million69.49 million52.50 million48.17 million
Next Earnings Date3/2/2021 (Confirmed)3/25/2021 (Estimated)3/4/2021 (Confirmed)3/2/2021 (Estimated)3/1/2021 (Confirmed)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.